Amia.ai is a pharma-first, AI-second company building regulatory-grade AI systems for life sciences. Founded by former Pfizer R&D leader Louis Lalas, Amia.ai combines deep regulatory domain expertise with enterprise AI execution to help biopharma teams accelerate compliant submissions and QA workflows.

Key highlights

• Founded by ex-Pfizer R&D leadership with hands-on IND and NDA experience
• Biopharma experience across Gilead, Bristol Myers Squibb, Amgen, and Pfizer
• Enterprise AI deployments at Humana, eBay, Walmart, and Caterpillar
• MedNova, an agentic AI platform for regulatory, clinical, and quality teams
• Automates IND, NDA, CMC, and clinical documentation
• QA validation automation for IQ, OQ, and PQ protocols and reports
• Built by pharma veterans with experience across 15+ NDA submissions
• Designed for compliance, audit readiness, and secure enterprise deployment